Maleisië - Engels - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

orion pharma (my) sdn. bhd. - quetiapine fumarate -

Verenigde Staten - Engels - NLM (National Library of Medicine)

ax pharmaceutical corp - human chorionic gonadotropin (unii: 20ed16gheb) (chorionic gonadotropin - unii:20ed16gheb) - human chorionic gonadotropin 990000 [iu] in 1000000 [iu]

Malta - Engels - Malta Medicines Authority

ferring pharmaceuticals limited drayton hall, church road, west drayton ub7 7ps, united kingdom - chorionic gonadotrophin, human - powder and solvent for solution for injection - chorionic gonadotrophin, human 1500 iu - sex hormones and modulators of the genital system

Malta - Engels - Malta Medicines Authority

ferring pharmaceuticals limited drayton hall, church road, west drayton ub7 7ps, united kingdom - chorionic gonadotrophin, human - powder and solvent for solution for injection - chorionic gonadotrophin, human 5000 iu - sex hormones and modulators of the genital system

Australië - Engels - Department of Health (Therapeutic Goods Administration)

orion pharma (aus) pty limited - estradiol, quantity: 1 mg/g - gel - excipient ingredients: purified water; propylene glycol; carbomer 934p; ethanol; trolamine - short-term treatment of climacteric symptoms after natural or surgical menopause. whenever possible the lowest effective dose should be used. review the need for continuation of treatment after 6 months, taking into account the risk-benefit ratio for the individual user at that moment (including cardiovascular disease and breast cancer, see section 5.1 pharmacodynamic properties - clinical trials and section 4.4 special warnings and precautions for use). sandrena should only be continued for as long as the benefit outweighs the risks

Singapore - Engels - HSA (Health Sciences Authority)

orion pharma (sg) pte. ltd. - methotrexate - tablet - 2.5 mg - methotrexate 2.5 mg

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 100mg - capsule - 100 mg - active: temozolomide 100mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 140mg - capsule - 140 mg - active: temozolomide 140mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 180mg - capsule - 180 mg - active: temozolomide 180mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

orion laboratories (nz) ltd - temozolomide 20mg - capsule - 20 mg - active: temozolomide 20mg excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid titanium dioxide - treatment of: - patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment - patients with recurrent high grade glioma, such as glioblastoma multiforme or anaplastic astrocytoma